Cite
Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer
MLA
Thompson, R.Houston, et al. “Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Immunotherapy for the Treatment of Prostate Cancer.” Urologic Oncology, vol. 24, no. 5, Sept. 2006, pp. 442–47. EBSCOhost, https://doi.org/10.1016/j.urolonc.2005.08.011.
APA
Thompson, R. H., Allison, J. P., & Kwon, E. D. (2006). Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer. Urologic Oncology, 24(5), 442–447. https://doi.org/10.1016/j.urolonc.2005.08.011
Chicago
Thompson, R. Houston, James P. Allison, and Eugene D. Kwon. 2006. “Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Immunotherapy for the Treatment of Prostate Cancer.” Urologic Oncology 24 (5): 442–47. doi:10.1016/j.urolonc.2005.08.011.